Company news

EVE Health Group Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Meluka Honey Appoints OpenDNA for Chinese Market Entry

March 11, 2019

EVE to Acquire Remaining 50% of Meluka Health

February 24, 2019

Response to ASX Appendix 4C Query

February 19, 2019

Meluka Honey Secures Distribution for NSW & ACT

November 13, 2018

Meluka Honey Combines Anti-Microbial & Anti-Oxidant Activity

November 7, 2018

Appendix 4E and Full Year Statutory Accounts

August 31, 2018

Completion of THC Agreements

July 24, 2018

Omni Innovation - Update by Eagle Health on Chinese Market

July 15, 2018

Update on THC Agreements

July 2, 2018

EVE to Acquire Leading Aust Organic Tea Tree Oil Producer

June 20, 2018

First Quarter China Sales Progress

April 26, 2018

Half Yearly Report and Accounts

February 26, 2018

Meluka Consumer Products Launch at US Natural Products Expo

February 22, 2018

Oversubscribed Placement & Rights Issue to Raise up to $6.3m

January 30, 2018

Eagle Begins Shipment of Omni Innovations Diabetes Product

December 7, 2017

Meluka Health to Develop Honey Water for Chinese Market

December 6, 2017

Eve Completes 50% Investment in Meluka Health

December 5, 2017

Response to ASX Price & Volume Query

November 30, 2017

NSW Grant for Honey Research Successful

November 26, 2017

Medic Honey Produces a Hemp Seed Honey

November 21, 2017

Supply Agmt with Large Producer of Australian Organic Honey

November 5, 2017

Eagle Commences Production of Omnis Pre-Meal Diabetes Shake

October 30, 2017

Appendix 4C - Quarterly

October 20, 2017

$1.2m Capital Raising

October 5, 2017

Revised Medical Honey Investment Structure

August 27, 2017

Omni Innovation Enters Chinese Distribution Agreement

August 16, 2017

Accelerating Portfolio Progress

June 25, 2017

Southern Cross University Collaboration with Medic Honey

May 29, 2017

Omni Innovation - US Patent Notice of Allowance Received

February 28, 2017

Sales Results Exceed Expectations for Faulding GlucoControl

January 24, 2017

$1.6m Placement for Omni Innovation Investment

December 23, 2016

Notification of Rights Issue Shortfall

December 9, 2016

Omni Innovation Market Update

December 1, 2016

Omni Innovation secures UK Distribution Deal

November 20, 2016

Placement to Chinese Pharmaceutical and Investment Group

November 9, 2016

New Study- GlucoControl Improves Long-Term Glycaemic Control

September 20, 2016

Omniblend Innovation Enters into US Representation Deal

August 23, 2016

GlucoControl Momentum

July 4, 2016

GlucoControl Pre-Meal Drink Launched

May 5, 2016

Extension of Omniblend Innovation Tranche 2 Settlement

March 31, 2016

Non-Renounceable Issue

March 30, 2016

GlucoControl Product Manufacturing Commences

February 25, 2016

Fully Underwritten Rights Issue

February 18, 2016

EVE Investments makes first medical technology investment

February 11, 2016

EVE: Company Update

February 10, 2016

Energy Ventures: 13 November 2015 - Net Tangible Asset Backing

November 12, 2015

Energy Ventures: 19 October 2015 - Prospectus

October 18, 2015

Energy Ventures: 19 October 2015 - Notice of Annual General Meeting/Proxy Form

October 18, 2015

Energy Ventures: 19 October 2015 - Appendix 4G and Corporate Governance Statement

October 18, 2015

Energy Ventures: 19 October 2015 - Annual Report to Shareholders

October 18, 2015

← Newer news releases

Decks

The 5 newest of 34 decks. Every deck is listed under its year.